Skip to content

The Biodiversity-Global Health Nexus: Implications for Access and Benefit Sharing

The Biodiversity-Global Health Nexus: Implications for Access and Benefit Sharing
Image Credit: Pexels, Steve A Johnson

Newsletter Edition #176 [Treaty Talks]


Dear Readers, 

It has been our every effort to connect developments across policy spheres to better understand implications for global health.

In today's edition, we bring you a guest essay that discusses the recently concluded United Nations Biodiversity Conference that took place in Armenia, and examines the implications for the Pathogen Access and Benefit-Sharing System, under negotiation at the World Health Organization.

We are grateful to Matthew Carvalho, a legal expert and the Chair of the Health Diplomacy Youth Network at the Health Diplomacy Alliance, for bring this analysis for our readers.

We hope you find this useful.

We will be sharing an analysis on the WHO election processes this week in a forthcoming update. We are still gathering intel on how member states are responding to what they saw and heard. Thank you for understanding.
Separately, I also spoke about the WHO elections for the Global Order podcast from the Georgetown Center for Global Health Policy & Politics (this was prior to the Candidates Forum). You can have a listen here.

Geneva Health Files offers value to our readers who are experts in global health. Tracking global health policy-making in Geneva is tough and expensive, without institutional support. For six years, we have provided you with the information and tools that directly contribute to your work in the field. We rely on our readers who value news they can use.

By becoming a paying subscriber you make our work possible and help us gather, report and synthesise global health intelligence.


Best,

Priti

Priti Patnaik, Founder & Publisher, Geneva Health Files

Feel free to write to us: genevahealthfiles@gmail.com ; Find us on BlueSky, Instagram and Linkedin.


Presenting our weekly in-depth analysis on global health that captures the big picture and the nuances like no one else does. This is an exclusive edition for our subscribers.

I. GUEST ESSAY

The Biodiversity-Global Health Nexus: Implications for Access and Benefit Sharing

Reflections from the 17th United Nations Biodiversity Conference and Implications for the Pathogen Access and Benefit-Sharing System

By Matthew Carvalho

Carvalho is a J.D. Candidate at Georgetown University Law Center in the U.S., and Chair of the Health Diplomacy Youth Network at the Health Diplomacy Alliance. He can be reached at mpc129@georgetown.edu or mcarvalho@hdalliance.org.


While many trackers of global health law developments prepared to head to Geneva for the recently concluded session of the Intergovernmental Working Group (IGWG) for the World Health Organization (WHO) Pandemic Agreement, I found myself traveling further east: for the last two weeks of October, the 17th United Nations (UN) Biodiversity Conference, or COP17, was held in Yerevan, Armenia, under the theme “Taking Action for Nature.”

The thematic relationship between biodiversity and global health is sometimes a bit harder to track than, say, climate and health, but the field has grown larger over time. In particular, the biodiversity negotiations even have a workstream dedicated to biodiversity and health looking to further explore these synergies.

However, those who follow the Pathogen Access and Benefit-Sharing (PABS) System negotiations know that the Convention on Biological Diversity (CBD) and its Nagoya Protocol are also the legal foundation for international access and benefit-sharing (ABS) law, and the negotiations this year in particular had significant implications for ABS negotiations across specialized regimes.

Digital Sequence Information, Two Years Out

From our partners